340B Plan B: Pharma Pivots To Rebate Pricing Model After Pharmacy Restrictions Fall Short
The manufacturer dispute with hospitals and US agency tasked with overseeing the outpatient drug discount program is entering a new phase.
The manufacturer dispute with hospitals and US agency tasked with overseeing the outpatient drug discount program is entering a new phase.